Business Description
Firebrick Pharma Ltd
ISIN : AU0000197352
Compare
Compare
Traded in other countries / regions
FRE.Australia IPO Date
2022-01-28Description
Firebrick Pharma Ltd is an Australian pharmaceutical developer. It is engaged in the development and commercialization of povidone-iodine (PVP-I) products under the Nasodine brand. Its Nasodine Nasal Spray which is in the commercialization phase, is a broad-spectrum anti-viral spray, designed to be an effective treatment and prevention of respiratory viral infections such as the common cold. In parallel, the company is also engaged in the development of the follow-on Nasodine brand products.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.88 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 14.38 | |||||
| Beneish M-Score | 5.86 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Book Growth Rate | -45.5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 34.85 | |||||
| 9-Day RSI | 40.17 | |||||
| 14-Day RSI | 42.43 | |||||
| 6-1 Month Momentum % | -5 | |||||
| 12-1 Month Momentum % | -13.64 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 7.19 | |||||
| Quick Ratio | 6.36 | |||||
| Cash Ratio | 2.84 | |||||
| Days Inventory | 2579.66 | |||||
| Days Sales Outstanding | 2007.5 | |||||
| Days Payable | 1598.11 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -5 | |||||
| Shareholder Yield % | -6.8 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -164.29 | |||||
| Operating Margin % | -28057.14 | |||||
| Net Margin % | -8392.86 | |||||
| FCF Margin % | -16750 | |||||
| ROE % | -57.04 | |||||
| ROA % | -48.07 | |||||
| ROIC % | -499.11 | |||||
| ROC (Joel Greenblatt) % | -1194.92 | |||||
| ROCE % | -57.04 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 4.65 | |||||
| Price-to-Tangible-Book | 5.1 | |||||
| EV-to-EBIT | -8.59 | |||||
| EV-to-EBITDA | -8.65 | |||||
| EV-to-Revenue | 721.5 | |||||
| EV-to-FCF | -4.76 | |||||
| Price-to-Net-Current-Asset-Value | 5.1 | |||||
| Earnings Yield (Greenblatt) % | -11.63 | |||||
| FCF Yield % | -21.47 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Firebrick Pharma Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 0.014 | ||
| EPS (TTM) (A$) | -0.007 | ||
| Beta | 0 | ||
| Volatility % | 53.9 | ||
| 14-Day RSI | 42.43 | ||
| 14-Day ATR (A$) | 0.002182 | ||
| 20-Day SMA (A$) | 0.0542 | ||
| 12-1 Month Momentum % | -13.64 | ||
| 52-Week Range (A$) | 0.045 - 0.11 | ||
| Shares Outstanding (Mil) | 210.11 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Firebrick Pharma Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Firebrick Pharma Ltd Stock Events
| Event | Date | Price(A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Firebrick Pharma Ltd Frequently Asked Questions
What is Firebrick Pharma Ltd(ASX:FRE)'s stock price today?
The current price of ASX:FRE is A$0.05. The 52 week high of ASX:FRE is A$0.11 and 52 week low is A$0.05.
When is next earnings date of Firebrick Pharma Ltd(ASX:FRE)?
The next earnings date of Firebrick Pharma Ltd(ASX:FRE) is .
Does Firebrick Pharma Ltd(ASX:FRE) pay dividends? If so, how much?
Firebrick Pharma Ltd(ASX:FRE) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers